Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2

被引：0
|
作者：
Vidya Niranjan
Anagha Shamsundar Setlur
Chandrashekar Karunakaran
Akshay Uttarkar
Kalavathi Murugan Kumar
Sinosh Skariyachan
机构：
[1] RV College of Engineering,Department of Biotechnology
[2] Pondicherry University,Department of Bioinformatics
[3] St. Pius X College,Department of Microbiology
来源：
Structural Chemistry | 2022年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2263 / 2263
相关论文
共 50 条
  • [31] Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
    Canrong Wu
    Yang Liu
    Yueying Yang
    Peng Zhang
    Wu Zhong
    Yali Wang
    Qiqi Wang
    Yang Xu
    Mingxue Li
    Xingzhou Li
    Mengzhu Zheng
    Lixia Chen
    Hua Li
    Acta Pharmaceutica Sinica B, 2020, 10 (05) : 766 - 788
  • [32] Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
    Wu, Canrong
    Liu, Yang
    Yang, Yueying
    Zhang, Peng
    Zhong, Wu
    Wang, Yali
    Wang, Qiqi
    Xu, Yang
    Li, Mingxue
    Li, Xingzhou
    Zheng, Mengzhu
    Chen, Lixia
    Li, Hua
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (05) : 766 - 788
  • [33] Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
    Yu, Wenhui
    Bai, Yuxin
    Raha, Arjun
    Su, Zhi
    Geng, Fei
    FRONTIERS IN BIOINFORMATICS, 2022, 1
  • [34] Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease
    Ghosh, Suvankar
    Bhattacherjee, Debojit
    Satpati, Priyadarshi
    Bhabak, Krishna Pada
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (22): : 12088 - 12099
  • [35] A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2
    Simonis, Alexander
    Theobald, Sebastian J.
    Fatkenheuer, Gerd
    Rybniker, Jan
    Malin, Jakob J.
    EMBO MOLECULAR MEDICINE, 2021, 13 (01)
  • [36] Bispecifics Potential to Fight SARS-CoV-2 Variants
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (06) : 1417 - 1417
  • [37] What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
    Martinez, Miguel Angel
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [38] Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs
    Skariyachan, Sinosh
    Gopal, Dharshini
    Chakrabarti, Shweta
    Kempanna, Priya
    Uttarkar, Akshay
    Muddebihalkar, Aditi G.
    Niranjan, Vidya
    COMPUTERS IN BIOLOGY AND MEDICINE, 2020, 126 (126)
  • [39] Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants
    Daniela Iaconis
    Licia Bordi
    Giulia Matusali
    Carmine Talarico
    Candida Manelfi
    Maria Candida Cesta
    Mara Zippoli
    Francesca Caccuri
    Antonella Bugatti
    Alberto Zani
    Federica Filippini
    Laura Scorzolini
    Marco Gobbi
    Marten Beeg
    Arianna Piotti
    Monica Montopoli
    Veronica Cocetta
    Silvia Bressan
    Enrico M. Bucci
    Arnaldo Caruso
    Emanuele Nicastri
    Marcello Allegretti
    Andrea R. Beccari
    Cell Death & Disease, 13
  • [40] Gene expression network analysis provides potential targets against SARS-CoV-2
    Ana I. Hernández Cordero
    Xuan Li
    Chen Xi Yang
    Stephen Milne
    Yohan Bossé
    Philippe Joubert
    Wim Timens
    Maarten van den Berge
    David Nickle
    Ke Hao
    Don D. Sin
    Scientific Reports, 10
12345